Peptide therapy can improve metabolic health and appetite regulation through GLP-1 analogues and related metabolic peptides
This group of early adopters reports being relatively dissatisfied with current solutions, expressing the need for more advanced features that better support template personalization, patient education materials, and automation of repetitive processes like lab, imaging, and referral orders
Both peptides are administered through subcutaneous injection once per week
Compounded medications are prepared by licensed compounding pharmacies based on individual prescriptions
Supplementary material The Supplementary Material for this article can be found online at: Abbreviations CSII, continuous subcutaneous insulin infusion
Ozempic mimics a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP1)